These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Joint inflammation and cytokine inhibition in rheumatoid arthritis. Christodoulou C; Choy EH Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339 [TBL] [Abstract][Full Text] [Related]
3. Evidence that cytokines play a role in rheumatoid arthritis. Brennan FM; McInnes IB J Clin Invest; 2008 Nov; 118(11):3537-45. PubMed ID: 18982160 [TBL] [Abstract][Full Text] [Related]
4. New concepts in the treatment of rheumatoid arthritis. Goldbach-Mansky R; Lipsky PE Annu Rev Med; 2003; 54():197-216. PubMed ID: 12359827 [TBL] [Abstract][Full Text] [Related]
5. Immunological therapies for rheumatoid arthritis. Edwards CJ Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791 [TBL] [Abstract][Full Text] [Related]
6. New therapies for rheumatoid arthritis. Goldblatt F; Isenberg DA Clin Exp Immunol; 2005 May; 140(2):195-204. PubMed ID: 15807842 [TBL] [Abstract][Full Text] [Related]
8. Clinical experience with inhibition of interleukin-6. Choy E Rheum Dis Clin North Am; 2004 May; 30(2):405-15, viii. PubMed ID: 15172049 [TBL] [Abstract][Full Text] [Related]
10. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL; Watson KD; Silman AJ; Symmons DP; Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046 [TBL] [Abstract][Full Text] [Related]
11. Emerging therapeutics for rheumatoid arthritis. Bingham CO Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634 [TBL] [Abstract][Full Text] [Related]
13. [Biopharmaceuticals in the treatment of rheumatoid arthritis]. Baslund B; Bendtzen K Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481 [TBL] [Abstract][Full Text] [Related]
14. Update in rheumatoid arthritis therapy. Kim-Howard XR; Staudt L; James JA J Okla State Med Assoc; 2005 Feb; 98(2):53-62. PubMed ID: 15789642 [TBL] [Abstract][Full Text] [Related]
15. When to initiate and discontinue biologic treatments for rheumatoid arthritis? Chatzidionysiou K; van Vollenhoven RF J Intern Med; 2011 Jun; 269(6):614-25. PubMed ID: 21261760 [TBL] [Abstract][Full Text] [Related]
16. Emerging therapies for rheumatoid arthritis. Jacques P; Van den Bosch F Expert Opin Emerg Drugs; 2013 Jun; 18(2):231-44. PubMed ID: 23725568 [TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis: an overview of new and emerging therapies. Doan T; Massarotti E J Clin Pharmacol; 2005 Jul; 45(7):751-62. PubMed ID: 15951465 [TBL] [Abstract][Full Text] [Related]
18. Strategies for the management of rheumatoid arthritis. Wilkie WS; Schwieterman P Orthopedics; 2012 Feb; 35(2):125-30. PubMed ID: 22300992 [TBL] [Abstract][Full Text] [Related]
19. TNF alpha as a therapeutic target in rheumatoid arthritis. Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor inactivation in the management of rheumatoid arthritis. Baumgartner SW South Med J; 2000 Aug; 93(8):753-9. PubMed ID: 10963503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]